Table 5.

POAG prevalence by age and sex, 2010, AOK data

	Age	Prevalence (%), 95%-CI (Binomial Exact)		Prevalent persons		Persons on 01.01.2010
Males	50–54	0.84	(0.74–0.95)1	252	8.0%	29,949
	55–59	1.38	(1.21–1.57)	227	7.2%	16,418
	60–64	2.07	(1.83–2.33)	271	8.7%	13,090
	65–69	3.27	(2.99–3.57)	473	15.1%	14,465
	70–74	4.44	(4.13–4.77)	715	22.8%	16,102
	75–79	5.32	(4.90–5.76)	562	17.9%	10,568
	80–84	6.06	(5.49–6.66)	400	12.8%	6605
	85–89	6.91	(5.98–7.93)	186	5.9%	2693
	90+	5.89	(4.34–7.78)	46	1.5%	781
	Total			3132		110,671
Females	50–54	0.84	(0.73–0.95)	242	4.8%	28,932
	55–59	1.58	(1.39–1.78)	264	5.2%	16,739
	60–64	2.47	(2.21–2.74)	334	6.6%	13,538
	65–69	3.83	(3.54–4.14)	614	12.2%	16,042
	70–74	5.02	(4.72–5.33)	1007	20.0%	20,070
	75–79	6.15	(5.80–6.52)	1043	20.7%	16,953
	80–84	6.25	(5.85–6.66)	860	17.1%	13,770
	85–89	5.49	(5.03–5.97)	510	10.1%	9296
	90+	4.04	(3.45–4.69)	161	3.2%	3989
	Total			5035		139,329
Total	50–54	0.84	(0.77–0.92)	494	6.0%	58,881
	55–59	1.48	(1.35–1.62)	491	6.0%	33,157
	60–64	2.27	(2.10–2.46)	605	7.4%	26,628
	65–69	3.56	(3.36–3.78)	1087	13.3%	30,507
	70–74	4.76	(4.54–4.99)	1722	21.1%	36,172
	75–79	5.83	(5.56–6.12)	1605	19.7%	27,521
	80–84	6.18	(5.86–6.52)	1260	15.4%	20,375
	85–89	5.81	(5.39–6.24)	696	8.5%	11,989
	90+	4.34	(3.78–4.96)	207	2.5%	4770
	Total			8167		250,000